BIOMAT Database Logo BIOMAT Database Logo

Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators. 2015

Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: takafumi.takai@takeda.com.

Novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives were designed, synthesized, and evaluated as γ-secretase modulators (GSMs). An optimization study of this series resulted in the identification of (R)-11j, which showed a potent Aβ42-lowering effect, high bioavailability and good blood-brain barrier permeability in mice. Oral administration of (R)-11j significantly reduced brain Aβ42 in mice at a dose of 10 mg/kg.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid

Related Publications

Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
July 2016, Bioorganic & medicinal chemistry,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Efficient synthesis and evaluation of novel 6-arylamino-[1,2,4]triazolo[4,3-a]pyridine derivatives as antiproliferative agents.
November 2022, Bioorganic & medicinal chemistry letters,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
October 2017, Bioorganic & medicinal chemistry letters,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
November 2017, Bioorganic & medicinal chemistry letters,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors.
November 2021, European journal of medicinal chemistry,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Pyridine-derived γ-secretase modulators.
August 2011, Bioorganic & medicinal chemistry letters,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors.
August 2016, Bioorganic & medicinal chemistry,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Synthesis, crystal structure, herbicidal activities and 3D-QSAR study of some novel 1,2,4-triazolo[4,3-a]pyridine derivatives.
February 2015, Pest management science,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators.
January 2020, Bioorganic & medicinal chemistry,
Takafumi Takai, and Yasutaka Hoashi, and Yoshihide Tomata, and Sachie Morimoto, and Minoru Nakamura, and Tomomichi Watanabe, and Tomoko Igari, and Tatsuki Koike
Discovery of triazolo [1,5-a] pyridine derivatives as novel JAK1/2 inhibitors.
July 2020, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!